International Trade Today is a service of Warren Communications News.

Hard Empty Capsules: Prelim CVD Cash Deposit Rates Take Effect for 4 Countries

Suspension of liquidation and countervailing duty cash deposit requirements took effect March 31 for imports of hard empty capsules from Brazil (C-351-865), China (C-570-185), India (C-533-935) and Vietnam (C-552-848), after the Commerce Department found countervailable subsidization in preliminary determinations in its ongoing CVD investigations.

Sign up for a free preview to unlock the rest of this article

If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.

Commerce is also conducting concurrent antidumping duty investigations on hard empty capsules from Brazil, China, India and Vietnam, with Commerce's preliminary AD determinations currently due May 22.

CVD Suspension of Liquidation and Cash Deposit Requirements

Commerce will instruct CBP to suspend liquidation for CVD purposes for all entries of subject merchandise from Brazil, China, India and Vietnam that are entered, or withdrawn from warehouse, for consumption on or after March 31. It will require CVD cash deposits at the following rates:

Brazil

CompanyCVD Rate
ACG do Brasil S.A4.94%
All Others4.94%

China

CompanyCVD Rate
Jiangsu Lefan Capsule Co., Ltd3.45%
Shanxi JC Biological Technology Co., Ltd8.53%
All Others6.82%

India

CompanyCVD Rate
ACG Associated Capsules Private Limited; ACG Pam Pharma Technologies Private Limited; ACG Universal Capsules Private Limited9.95%
All Others9.95%

Vietnam

CompanyCVD Rate
Suheung Vietnam Co., Ltd2.15%
All Others2.15%

(The period of investigation for Brazil, China and Vietnam is 01/01/23 - 12/31/23, and for India it's 04/01/23 - 03/31/24. See Commerce's notice for more information, including the scope (unchanged), suspension of liquidation, etc. See 2411200027 for a summary of the initiation of these CVD investigations, including deadlines and scope information.)